Title: Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
Authors: Barst, Robyn J ×
Langleben, David
Badesch, David
Frost, Adaani
Lawrence, E Clinton
Shapiro, Shelley
Naeije, Robert
Galie, Nazzareno
STRIDE-2 Study Group #
Contributors: Delcroix, Marion
Issue Date: May-2006
Publisher: Elsevier Biomedical
Series Title: Journal of the American College of Cardiology vol:47 issue:10 pages:2049-2056
Abstract: We sought to determine the optimal dose of the selective endothelin A (ET(A)) receptor antagonist sitaxsentan for the treatment of pulmonary arterial hypertension (PAH); for observation only, an open-label (OL) bosentan arm was included.
ISSN: 0735-1097
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Pneumology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science